Latest News
Total
30
-
2025 / 01 / 23Hi-Q Marine Biotech is proud to announce that two of our flagship products have achieved SNQ certification for 2025: ONCOFUCO® and BALANGLUCO® -
2024 / 12 / 31Dr. Wen-Rui Hao from the Division of Cardiology, Shuang Ho Hospital, has led groundbreaking research using Hi-Q's innovative ingredient, OliFuco®. The study results have been published in the prestigious journal Biomedicines. -
2024 / 12 / 02The use of dietary supplements as part of daily health maintenance and for improving physical well-being is becoming increasingly common. Hi-Q’s branded dietary supplement ONCOFUCO Oligo Fucoidan has emerged as the leading brand in Taiwan's fucoidan market, ranking first in both brand recognition and market share. To date, Hi-Q ONCOFUCO has accumulated 20 internationally recognized certifications, demonstrating its credibility and authority in the industry. -
2024 / 11 / 19Hi-Q Marine Biotech is honored to support the Taiwan Breast Cancer Foundation (TBCF) in their efforts to promote breast cancer awareness and early prevention. This meaningful initiative aligns with our commitment to fostering health and well-being within our community. -
2024 / 10 / 01Honored to be part of the 2024 Agricultural Value-Added Processing Industry Forum hosted by the Ministry of Agriculture on September 30th at National Taiwan University International Conference Center. -
2024 / 09 / 30At Hi-Q, we are deeply committed to giving back to our community. One of the initiatives closest to our hearts is the 1919 After-School Tutoring for Disadvantaged Children, which we have proudly supported for many years. This year, we are honored to be one of the main sponsors of this impactful cause -
2024 / 08 / 07Hi-Q is pleased to announce the publication of our study investigating the use of OliFuco® Oligo Fucoidan, our proprietary ingredient, as an adjunct therapy for lung cancer. Given lung cancer’s high incidence and mortality rates, particularly in Taiwan, our research focused on evaluating how adding OliFuco® to conventional treatments could impact patient outcomes. -
.jpg)
2024 / 07 / 25We are pleased to announce the official launch of FucoSkin® CS, our latest raw material that embodies our commitment to environmental protection and sustainable beauty. This new addition to our FucoSkin® line has achieved COSMOS Approved status, certified by Ecocert, reflecting our dedication to green chemistry and responsible use of natural resources.
-
2024 / 05 / 24Last Saturday (18th May), Hi-Q's founder, Mr. Johnson Chang, and co-founder, Mr. Philip Hsieh, along with several colleagues, participated in an open water swimming event in Green Island (綠島, Taiwan). Remarkably, both Mr. Chang and Mr. Hsieh are over 70 years old, yet they remain sharp and active. Their secret? Maintaining a healthy lifestyle and frequent swimming.
-
2024 / 02 / 17Explore our latest interview with Fortune Magazine/Voices of Leaders on how Hi-Q plays a pivotal role in bridging the cancer care gap through the development of innovative supplementary health products -
2023 / 09 / 27Super exciting news from Singapore! Hi-Q has been honored with the prestigious NutraIngredients-Asia Award, often referred to as the "Oscar" in the global nutritional ingredient industry! This achievement signifies a remarkable leap forward for Hi-Q.
-
2023 / 05 / 04Hi-Q has been recognized for its long-standing commitment to public welfare with its "Fish One For One" donation program, earning the ESG Award. Out of 236 entries, only 46 were selected for the award, with a winning rate of just 19.5%. Hi-Q is one of the few small and medium-sized enterprises among the winners, which was highly praised by the judges.
